Table 2.
Characteristic | CECaT n = 898 |
ACRE n = 2419 |
PMR n = 73 |
TMR n = 188 |
SPiRiT n = 68 |
EVAD Tx WL n = 47 |
---|---|---|---|---|---|---|
Mean baseline EQ-5D (SD) | 0.77 (0.22) | --- | 0.48 (0.30) | 0.43 (0.29) | 0.44 (0.30) | 0.51 (0.27) |
Mean age (SD) | 62 (9.4) | 60 (9.7) | 62 (6.4) | 60 (7.6) | 64 (8.4) | 48 (11.7) |
Gender | ||||||
Male (%) | 619 (69) | 1701 (70) | 69 (95) | 169 (90) | 60 (88) | 39 (83) |
Female (%) | 279 (31) | 718 (30) | 4 (5) | 19 (10) | 8 (12) | 8 (17) |
Diabetes | ||||||
Yes (%) | 36 (4) | 263 (11) | N/A | 33 (18) | 6 (9) | N/A |
No (%) | 862 (96) | 2156 (89) | N/A | 155 (82) | 62 (91) | N/A |
Previous heart attack/angioplasty/ revascularization |
||||||
Yes (%) | 342 (38) | N/A | 71 (97) | 185 (98) | 67 (99) | N/A |
No (%) | 556 (62) | N/A | 2 (3) | 3 (2) | 1 (1) | N/A |
CCS or NYHA class* | ||||||
0 (%) | 59 (7) | 258 (11) | --- | --- | --- | |
I (%) | 191 (21) | 185 (8) | --- | --- | --- | --- |
II (%) | 536 (60) | 496 (21) | --- | --- | --- | --- |
III (%) | 100 (11) | 211 (9) | 48 (66) | 143 (76) | 47 (69) | 18 (38) |
IV (%) | 12 (1) | 639 (26) | 25 (34) | 43 (23) | 21 (31) | 7 (15) |
Key: CECaT - Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary heart disease study, ACRE - Appropriateness for coronary revascularization study, PMR - Percutaneous myocardial revascularization compared to continued medical therapy study, TMR - Transmyocardial laser revascularization compared to continued medical therapy study, SPiRiT - Spinal cord stimulation (SCS) compared to PMR study, EVAD - Evaluation of ventricular assist devices (VAD) patients compared to patients on transplant waiting list (Tx WL) study, EQ-5D - Euroqol 5D, SD - standard deviation, CCS - Canadian Cardiovascular Society angina classification, NYHA - New York Heart Association angina classification
*CCS class for all but EVAD groups. In the case where percentages do not sum to 100, it is due to missing values.